Abstract
It has recently been shown that the rare and ominous disease called « lethal midline granuloma » was in fact a true malignant lymphoma in most cases [1]. This disease represents a formidable challenge for the clinician: he has first to reach the diagnosis by the exclusion of dozens of other diseases capable of destroying the center of the face; then he must select a curative treatment together with supportive measures including nutrition therapy in those cachectic patients; and he must manage severe sepsis problems arising from the ulcerated face. We present here our 10-year experience of those ulcerative lymphomas of the midface (ULM).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grange CI, Cabane J, Dubois A, Raphael M, Chomette G, Lamas G, Godeau P, Meyer B, Imbert JC (1992) Centrofacial malignant granulomas. Clinicopathologic study of 40 cases and review of the literature. Medicine 71: 179–196
Stewart JP (1933) Progressive lethal granulomatous ulceration of the nose. J Laryngol 48: 657–701
Tsokos M, Fauci AS, Costa J (1982) Idiopathic midline destructive disease (IMDD). A subgroup of the patients with the « midline granuloma » syndrome. Am J Clin Pathol 77: 162–168
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Cabane, J., Grange, C., Lamas, G., Meyer, B., Godeau, P., Imbert, J.C. (1994). Response to chemotherapy of ulcerative lymphoma of the midface. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_56
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_56
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive